AstraZeneca
are the next pillar for in oncology | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
January 2022
Slide
30 of 42
Related slides by other companies
Genprex
Investor Presentation
October 2022
lead program non small cell lung cancer | Genprex
Genelux
Investor Presentation
October 2023
diversified designs and indications exploit competitive advantages bene | Genelux
Genelux
Investor Presentation
December 2023
program builds on completed trials to exploit competitive advantages estimated billion dollar plus annual commercial opportunity us | Genelux
Definitive Healthcare
Results
August 2023
the atlas delivers a true picture of your target market at one in start with looks like actually only | Definitive Healthcare
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights